Belatacept Is Associated with Improved Cardiovascular and Metabolic Risk Factors Compared to Cyclosporine in Kidney Transplant Patients (BENEFIT and BENEFIT-EXT Studies)

Vanrenterghem, Yves

Mancilla-Urrea, E ; Lang, P ; Agarwal, M ; Block, AJ ; Xing, J

Science & Technology, Life Sciences & Biomedicine, Surgery, Transplantation, 11 Medical and Health Sciences, 3202 Clinical sciences, 3204 Immunology